Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Janet Davison Rowley, Brian Druker, Nicholas Lydon

Premium

Janet Davison Rowley, the Blum-Riese Distinguished Service Professor of Medicine, Molecular Genetics, and Cell Biology and Human Genetics at the University of Chicago; Brian Druker of the Oregon Health and Science University; and Nicholas Lydon, formerly with Novartis, are the recipients of the 2012 Japan Prize for Healthcare and Medical Technology. They were awarded the prize for their roles in the development of the targeted anti-cancer drug Gleevec.

The three researchers "have made significant contributions to society by achieving momentous scientific and technological breakthroughs in creating and promoting new technologies for medical diagnosis and treatment," the Japan Prize Foundation said in a statement this week. They will each receive an equal share of 50 million Japanese Yen (approximately $215,000).

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.